𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Neutrophil trafficking into inflamed joints in patients with rheumatoid arthritis, and the effects of methylprednisolone

✍ Scribed by MB BS(HONS); FRACP Peter P. Youssef; John Cormack; Charles A. Evill; Daryl T. Peter; Peter J. Roberts-Thomson; Michael J. Ahern; Malcolm D. Smith


Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
922 KB
Volume
39
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

✦ Synopsis


Objective. To investigate the trafficking of circulating blood neutrophils and synovial fluid neutrophils in rheumatoid arthritis (RA) patients and the influence of a 1,000-mg intravenous pulse of methylprednisolone succinate (MP).

Methods. Neutrophils were isolated from the circulation and from the knee synovial compartments of subjects with RA. Circulating neutrophils were labeled with technetium-rn hexametazime (*Tc-HMPAO) and reinjected intravenously. Synovial fluid neutrophils were labeled with indium-111 oxine and reinjected into the knee from which they were isolated. Gamma camera images were obtained at intervals up to 24 hours post MP. Each patient had a baseline study (no MP) and a study in which MP was administered either 4 hours before (2 patients), 10 minutes before (1 patient), or 30 minutes to 1.5 hours after (6 patients) injection of the radiolabeled neutrophils. Subsequent analysis allowed quantitation of the neutrophil uptake into and clearance from the knee as a function of time.

Results. Nine patients who had not received glucocorticoids in the previous 3 months were studied. MP significantly decreased neutrophil ingress in 13 of the 16 knees studied (almost total inhibition in 5 knees), and this occurred within 1.5 hours of MP administration in all except 1 knee. At 24 hours after MP administra-


📜 SIMILAR VOLUMES


Accumulation of soluble fas in inflamed
✍ Tomoko Hasunuma; Nobuhiko Kayagaki; Hiroshi Asahara; Satoru Motokawa; Tetsuji Ko 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 603 KB

Objective. To examine the concentration of the soluble form of the Fas molecule (sFas) in the serum and synovial fluid of patients with rheumatoid arthritis (RA) and osteoarthritis (OA). Methods. The concentration of sFas in the serum of 15 normal subjects and in the synovial fluid and serum of 45

Expression of the thioredoxin–thioredoxi
✍ Madelon M. Maurice; Hajime Nakamura; Sonja Gringhuis; Takashi Okamoto; Shinichi 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 375 KB 👁 2 views

Objective. To examine the expression of the thioredoxin (TRX)-thioredoxin reductase (TR) system in patients with rheumatoid arthritis (RA) and patients with other rheumatic diseases. Methods. Levels of TRX in plasma and synovial fluid (SF) were measured using enzyme-linked immunosorbent assay. Cell

Soluble Fas ligand in the joints of pati
✍ Hideo Hashimoto; Masato Tanaka; Takashi Suda; Tetsuya Tomita; Kenji Hayashida; E 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 718 KB

Objective. To investigate the expression and function of Fas ligand (FasL),which can be in a membranebound or soluble form, in the joints of patients with rheumatoid arthritis (RA) and osteoarthritis (OA). Methods. The concentration of soluble FasL (sFasL) in serum and synovial fluid (SF) from 24 O